Refine by
Medical Data Software Articles & Analysis
32 news found
Planning brain surgery is a delicate process that requires precision to avoid damaging surrounding brain tissue and to prevent post-surgery complications. Synaptive Medical, a leader in medical technology, is set to enhance this process by evaluating its new software called Modus Plan, at Unity Health Toronto’s St. ...
BOSTON & LJUBLJANA, Slovenia--(BUSINESS WIRE)--Neutron Therapeutics, a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy (BNCT), and Cosylab, the world's leading provider of control systems for the planet's most complex machines, today announced that they have reached their second joint milestone in the clinical commissioning of Neutron ...
InHealth, who provide services for North and East Devon NHS Breast Screening, has entered into the research agreement to work with Kheiron Medical Technologies as part of the AI in Health & Care Award. This partnership marks another significant step in the journey to build an evidence base to demonstrate the effectiveness and safety of artificial intelligence in NHS breast cancer screening. ...
AI applications for medical imaging can improve prioritization, lesion detection, quantification and productivity Cloud-hosted platform provides access to AI applications that integrate into standard medical imaging workflow Market introduction to start in US and several European countries Strategically complements Bayer’s comprehensive portfolio of ...
ByBayer AG
BOSTON – June 22, 2022 – Elucid, a company developing a novel, non-invasive medical software to comprehensively characterize cardiovascular disease, announced the closing of a $27 Million Series B financing round. The round was led by an undisclosed strategic investor, with participation from Biovision Ventures, a new Europe-based fund, and existing investors, including MedTex ...
ByElucid
PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a diversified commercial-stage medical technology company, and its majority-owned subsidiary Lucid Diagnostics Inc. (Nasdaq: LUCD) (“Lucid”), a commercial-stage cancer prevention medical diagnostics company, today announced that PAVmed and Lucid Chairman & Chief Executive Officer Lishan Aklog, M.D. was selected as one of ...
How much do you know about the development of your favorite products? What about the devices you encounter at your doctor’s office? So much of the work that goes into every single thing we use remains unseen by the user or consumer, from concept development to design to ...
” Exo Works’ breakthrough mobile-first software is designed to reduce time and costs involved in accurately and securely documenting patient data while providing additional tools for real-time collaboration, credentialing and tracking key program metrics for departments and individuals. ...
ByExo
An experienced intellectual property attorney specializing in medical devices, software, and digital health, Nicholas Bero joins 4D Path as Chief Legal Officer. ...
About ILEX Medical ILEX Medical (established in 1977) is a part of ILEX Group, which has been publicly traded on the Tel Aviv Stock Exchange since 1995 (TASE:ILX). ...
Nanox.AI will host an on-site booth (booth 4949, South Hall Level 3) where the Company will showcase its AI-enabled medical imaging software population health solutions, as part of its value-based care offerings for healthcare systems and payers, expected to set a new standard in the medical technology sector. ...
Subtle Medical, a healthcare technology company using artificial intelligence to make medical imaging faster, safer, and smarter, announced today it has received a contract for image enhancement software solutions from Vizient, the largest member-driven health care performance improvement company in the country. Vizient’s diverse customer base includes academic medical centers, pediatric ...
The Nanox.ARC, together with the acquisitions of Zebra Medical Vision, that holds a large privately held diverse data repository and a strong regulatory framework including 8 FDA clearances alongside USARAD, with an extensive global network of over 300 certified radiologists, and the assets of its affiliated company, Medical Diagnostics Web, will ...
ORLANDO, FL – May 26, 2021 – AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTCMKTS: AVMR) today announces that its Chief Medical Officer, Farhan Taghizadeh, MD will reveal the latest developments in the field of digital surgery at the prestigious 13th 5CC World Congress to be held virtually in Barcelona this September ...
Nalu Medical, Inc. (“Nalu”), a Carlsbad, California-based company that has successfully miniaturized neurostimulation implants for the treatment of intractable chronic pain via Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS), announced the release of their latest software upgrade that adds new capabilities to their micro neurostimulation system. Like a smartphone ...
Xeltis CEO Eliane Schutte has been included in the Healthcare Technology Report’s list of 2021 Top 50 Healthcare Technology CEOs, one of only seven women featuring on the list. The Report’s list recognizes the most accomplished executives in the healthcare technology, whose leadership has been critical in developing industry leading medical devices, next generation software ...
ORLANDO, FL – February 11, 2021 – AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTCMKTS: AVMR) today issued the following update letter by its CEO, Barry Cohen to shareholders and the investment community: Dear AVRA Shareholder, As 2020 began, all things seemed pretty much as usual: we were fresh from the holidays and positively charged with optimism ...
The system, named Aura, is completely noninvasive, utilizing Empatica's medical smartwatches, software, and artificial intelligence capabilities. ...
The system, named Aura, is completely noninvasive, utilizing Empatica's medical smartwatches, software, and artificial intelligence capabilities. ...
ORLANDO, FL – January 17, 2020 – AVRA Medical Robotics, Inc. (the “Company”) (OTCQB: AVMR), a medical software and artificial intelligence company that is in the process of building a fully autonomous medical robotic system through the use of new technologies combining artificial intelligence, machine learning and proprietary software; is attending the 38th J.P. Morgan ...